pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
PFIZER · news · pharmadog
← back to PFIZER
News mentioning PFIZER
193
stories
29d
Webinar: From Clinical to Commercial: Talent Strategies for Biopharma Growth
biospace
29d
GSK lung cancer drug gets speedy approval following $10.6B deal
biopharma dive
Jul 22, 26
US ‘eroding’ lead in rare diseases a matter of national security: Report
biospace
Jul 22, 26
Royalty Pharma pens $425M deal for slice of sales on AstraZeneca’s ATTR drug
fiercebiotech
Jul 22, 26
AI data becomes sticking point in biopharma dealmaking
biospace
Jul 21, 26
Agios scraps sickle cell drug
biopharma dive
Jul 21, 26
Novartis stays 'geography-agnostic' in dealmaking amid flurry of China deals
biospace
Jul 21, 26
‘We’ve been looking for a novel approach’: Why Novartis CEO ended ADC holdout for $1.5B Myricx deal
fiercebiotech
Jul 17, 26
Quitting smoking is hard. A Medicare change may push doctors to give more help
stat
Jul 17, 26
Arbutus, Sanofi escalate mRNA patent fights; InnoCare’s TYK2 contender advances
biopharma dive
Jul 16, 26
Updated: Sanofi, Arbutus file separate suits against mRNA vaccine makers over LNP tech patents
endpoints
Jul 16, 26
Spurred by deep cuts and M&A activity, H1 layoffs could oust 14,000+ in biopharma
biospace
Jul 15, 26
Celcuity gains FDA approval for closely watched breast cancer drug
biopharma dive
Jul 15, 26
Merck ADC, in China study, shows potential to replace chemo in lung cancer
biopharma dive
Jul 15, 26
J&J dips despite upbeat outlook; AstraZeneca, Spero cut China deals
biopharma dive
Jul 13, 26
Agenus surges on study pivot; Apnimed lines up an IPO
biopharma dive
Jul 10, 26
Pfizer appoints obesity discovery head; AI startup Xaira makes leadership adjustments
endpoints
Jul 9, 26
AstraZeneca, Ionis drug fails big heart disease study in major setback
biopharma dive
Jul 8, 26
STAT+: Europe will accelerate its review of RevMed’s drug
stat
Jul 8, 26
STAT+: Pharmalittle: We’re reading about a Vera kidney drug approval, a U.K. Enhertu pricing deal, and more
stat
Jul 7, 26
Kailera says obesity pill succeeds in late-stage trial in China
biopharma dive
Jul 7, 26
Vertex to acquire Crinetics in $10B foray into endocrine disease drugs
biopharma dive
Jul 2, 26
STAT+: Up and down the ladder: The latest comings and goings
stat
Jul 1, 26
FDA says Zyn can market its pouches as safer than cigarettes
stat
Jun 30, 26
Beeline ups its Series A round for immune drug work
biopharma dive
Jun 30, 26
House China panel probes Bristol Myers, Pfizer on use of trial sites
endpoints
Jun 29, 26
10 clinical trials to watch in the second half of 2026
biopharma dive
Jun 26, 26
At BIO, tension over China biotech deal regulation looms
biopharma dive
Jun 26, 26
Alkermes’ incoming CEO has a plan to outplay Lilly and Takeda
biopharma dive
Jun 18, 26
Pfizer CFO to step down; Denali sells a regulatory fast-pass
biopharma dive
← prev
page 3 of 7
next →
